Increasing evidence links RNA methyltransferases to DNA damage repair. METTL16 is now shown to antagonize homologous recombination by preventing DNA-end resection via MRE11. Thus, METTL16 may represent a cancer vulnerability that can be used to identify patients able to benefit from combination therapies with DNA-damaging agents.
References
Alexandrov, L. B. et al. Nature 500, 415–421 (2013).
Zeng, X. et al. Nat. Cancer https://doi.org/10.1038/s43018-022-00429-3 (2022).
Oza, A. M. et al. Lancet Oncol. 16, 87–97 (2015).
Wilson, R. H. et al. Br. J. Cancer 116, 884–892 (2017).
Bendell, J. et al. Ann. Oncol. 26, 804–811 (2015).
Wang, X. et al. Nature 505, 117–120 (2014).
Alarcon, C. R., Lee, H., Goodarzi, H., Halberg, N. & Tavazoie, S. F. Nature 519, 482–485 (2015).
Lin, S., Choe, J., Du, P., Triboulet, R. & Gregory, R. I. Mol. Cell 62, 335–345 (2016).
Zhou, K. I. et al. Mol. Cell 76, 70–81 e79 (2019).
Pendleton, K. E. et al. Cell 169, 824–835 e814 (2017).
Xiang, Y. et al. Nature 543, 573–576 (2017).
Zhang, C. et al. Mol. Cell 79, 425–442 e427 (2020).
Svobodova Kovarikova, A. et al. Cells 9, 360 (2020).
Warda, A. S. et al. EMBO Rep. 18, 2004–2014 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Perez-Pepe, M., Alarcón, C.R. An RNA link for METTL16 and DNA repair in PDAC. Nat Cancer 3, 1018–1020 (2022). https://doi.org/10.1038/s43018-022-00434-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s43018-022-00434-6
- Springer Nature America, Inc.
This article is cited by
-
Methyltransferase-like proteins in cancer biology and potential therapeutic targeting
Journal of Hematology & Oncology (2023)
-
m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism
Molecular Cancer (2023)